Literature DB >> 7709447

Interferon-alpha-induced acute renal allograft rejection.

M Magnone1, J L Holley, R Shapiro, V Scantlebury, J McCauley, M Jordan, C Vivas, T Starzl, J P Johnson.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7709447      PMCID： PMC2962569          DOI： 10.1097/00007890-199504150-00030

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  14 in total

1.  The effects of interferon-alpha/beta in a model of rat heart transplantation.

Authors:  A D Slater; J B Klein; G Sonnenfeld; L L Ogden; L A Gray
Journal:  J Heart Lung Transplant       Date:  1992 Sep-Oct       Impact factor: 10.247

Review 2.  Interferons and interferon inducers in cancer treatment.

Authors:  S E Krown
Journal:  Semin Oncol       Date:  1986-06       Impact factor: 4.929

Review 3.  Immunophilins in protein folding and immunosuppression.

Authors:  D A Fruman; S J Burakoff; B E Bierer
Journal:  FASEB J       Date:  1994-04-01       Impact factor: 5.191

4.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

Authors:  A M Di Bisceglie; P Martin; C Kassianides; M Lisker-Melman; L Murray; J Waggoner; Z Goodman; S M Banks; J H Hoofnagle
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

5.  Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections.

Authors:  S H Cheeseman; R H Rubin; J A Stewart; N E Tolkoff-Rubin; A B Cosimi; K Cantell; J Gilbert; S Winkle; J T Herrin; P H Black; P S Russell; M S Hirsch
Journal:  N Engl J Med       Date:  1979-06-14       Impact factor: 91.245

6.  The alpha-interferon system in patients undergoing renal transplantation and treated with cyclosporine and prednisone.

Authors:  J L Ambrus; K C Chadha; S Anthone; R Anthone; S Sayyid
Journal:  Surg Gynecol Obstet       Date:  1993-06

7.  Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients.

Authors:  P Kramer; F W ten Kate; A B Bijnen; J Jeekel; W Weimar
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

8.  Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients.

Authors:  K V Rao; W R Anderson; B L Kasiske; D C Dahl
Journal:  Am J Med       Date:  1993-03       Impact factor: 4.965

9.  Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A.

Authors:  G H Reem; L A Cook; J Vilcek
Journal:  Science       Date:  1983-07-01       Impact factor: 47.728

10.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307
View more
  25 in total

Review 1.  Management of hepatitis C in patients with chronic kidney disease.

Authors:  Mohammad A B Al-Freah; Zeino Zeino; Michael A Heneghan
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 2.  Management of patients with hepatitis C infection and renal disease.

Authors:  Chalermrat Bunchorntavakul; Monthira Maneerattanaporn; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2015-02-27

Review 3.  Chronic viral hepatitis in kidney transplantation.

Authors:  Janna Huskey; Alexander C Wiseman
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

Review 4.  Kidney transplantation from donors with hepatitis C infection.

Authors:  Massimiliano Veroux; Daniela Corona; Nunziata Sinagra; Alessia Giaquinta; Domenico Zerbo; Burcin Ekser; Giuseppe Giuffrida; Pietro Caglià; Riccardo Gula; Vincenzo Ardita; Pierfrancesco Veroux
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

5.  Hepatitis B virus infection and liver transplantation.

Authors:  N A Terrault; T L Wright
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

6.  Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon.

Authors:  A Jain; A J Demetris; R Manez; A C Tsamanadas; D Van Thiel; J Rakela; T E Starzl; J J Fung
Journal:  Liver Transpl Surg       Date:  1998-05

7.  Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.

Authors:  Ioan Sporea; Alina Popescu; Roxana Sirli; Ovidiu Golea; Camelia Totolici; Mirela Danila; Corina Vernic
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

8.  Hepatitis C eradication and improvement of cryoglobulinemia-associated rash and membranoproliferative glomerulonephritis with interferon and ribavirin after kidney transplantation.

Authors:  Marilyn Zeman; Patricia Campbell; Vincent G Bain
Journal:  Can J Gastroenterol       Date:  2006-06       Impact factor: 3.522

9.  Type I interferons are not critical for skin allograft rejection or the generation of donor-specific CD8+ memory T cells.

Authors:  M H Oberbarnscheidt; J S Obhrai; A L Williams; D M Rothstein; W D Shlomchik; G Chalasani; F G Lakkis
Journal:  Am J Transplant       Date:  2009-11-24       Impact factor: 8.086

Review 10.  Managing chronic hepatitis C in the difficult-to-treat patient.

Authors:  Nyingi Kemmer; Guy W Neff
Journal:  Liver Int       Date:  2007-12       Impact factor: 5.828
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.